DIATECH DIABETES, INC.
AI-based algorithm that detects insulin infusion set failures in real-time by analyzing tissue counter pressure and continuous glucose monitoring data
- Sector
- Medtech
- Headquarters
- Memphis, FL
- Founded
- 2019
- Latest Form D
- $100K, Jul 2024
- Total capital
- $575K
- Federal grants
- $300K
- 1 award · 2021
- Rank in peer group#2 of 50
- Private capital raised
- $275K
- 5 Form D · last Jul 2024
- 27 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 3 pending · first 2022
- Rank in peer group#11 of 50
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$100K
- Federal grantHealth and Human S · Phase I · Development of a personalized infusion failure detection algorithm combining tissue counter pressure and blood glucose data for closed-loop diabetes management$300K
- Private capital raisedForm D · SEC · 4th filing$25K
- Private capital raisedForm D · SEC · 3rd filing$50K
- Private capital raisedForm D · SEC · 2nd filing$25K
- Private capital raisedForm D · SEC · 1st filing$75K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 50 peers
Line = medianMedtech · Software
- Federal grants#2 · top 4%
- Granted patents#11 · top 22%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Luis BlancoResearcherDirectorLinked by 1 patent
- John GrayResearcherDirectorLinked by $300K in grants as PI
- John WilcoxExecutive Officer, DirectorNamed in SEC Form D filings
- Nicholas CooperExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 4- PendingSystems And Methods For Detecting Disruptions In Fluid Delivery DevicesUSPTOApplication 18212596
- GrantedSystems and Methods for Detecting Disruptions in Fluid Delivery DevicesUSPTOUS 11,504,471
- PendingSystems And Methods For Detecting Disruptions In Fluid Delivery DevicesUSPTOApplication PCTUS2023025882
Show all 4 patent records
- Systems And Methods For Detecting Disruptions In Fluid Delivery DevicesNov 2, 2023 · Application 18212596Pending
- Systems and Methods for Detecting Disruptions in Fluid Delivery DevicesNov 22, 2022 · US 11,504,471Granted
- Systems And Methods For Detecting Disruptions In Fluid Delivery DevicesApplication PCTUS2023025882Pending
- Systems And Methods For Detecting Disruptions In Fluid Delivery DevicesApplication 63357885Pending
Related companies, and why
- GYNION, LLCSimilar federal contract value in Medtech · null in contracts
- SCIKON INNOVATION, INC.Similar federal contract value in Medtech · null in contracts
- TGen Tech, LLCSimilar federal contract value in Medtech · null in contracts
- VON MEDICAL, INCSimilar federal contract value in Medtech · null in contracts
- Autus Valve Technologies, Inc.Similar federal contract value in Medtech · null in contracts
- RECOVR, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .